BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22468630)

  • 1. Prolonged retention and in vivo evaluation of cationic nanoparticles loaded with Mitomycin C designed for intravesical chemotherapy of bladder tumours.
    Erdoğar N; Iskit AB; Mungan NA; Bilensoy E
    J Microencapsul; 2012; 29(6):576-82. PubMed ID: 22468630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors.
    Bilensoy E; Sarisozen C; Esendağli G; Doğan AL; Aktaş Y; Sen M; Mungan NA
    Int J Pharm; 2009 Apr; 371(1-2):170-6. PubMed ID: 19135514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cationic core-shell nanoparticles for intravesical chemotherapy in tumor-induced rat model: safety and efficacy.
    Erdogar N; İskit AB; Eroglu H; Sargon MF; Mungan NA; Bilensoy E
    Int J Pharm; 2014 Aug; 471(1-2):1-9. PubMed ID: 24836669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of both methotrexate and mitomycin C loaded PEGylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect.
    Jia M; Li Y; Yang X; Huang Y; Wu H; Huang Y; Lin J; Li Y; Hou Z; Zhang Q
    ACS Appl Mater Interfaces; 2014 Jul; 6(14):11413-23. PubMed ID: 24977925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor Efficacy of Bacillus Calmette-Guerin Loaded Cationic Nanoparticles for Intravesical Immunotherapy of Bladder Tumor Induced Rat Model.
    Erdoğar N; Iskit AB; Eroğlu H; Sargon MF; Mungan NA; Bilensoy E
    J Nanosci Nanotechnol; 2015 Dec; 15(12):10156-64. PubMed ID: 26682462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of in vitro parameters of tamoxifen citrate loaded poly(lactide-co-glycolide), poly(epsilon-caprolactone) and chitosan nanoparticles.
    Cirpanli Y; Yerlikaya F; Ozturk K; Erdogar N; Launay M; Gegu C; Leturgez T; Bilensoy E; Calis S; Capan Y
    Pharmazie; 2010 Dec; 65(12):867-70. PubMed ID: 21284254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivering instilled hydrophobic drug to the bladder by a cationic nanoparticle and thermo-sensitive hydrogel composite system.
    Men K; Liu W; Li L; Duan X; Wang P; Gou M; Wei X; Gao X; Wang B; Du Y; Huang M; Chen L; Qian Z; Wei Y
    Nanoscale; 2012 Oct; 4(20):6425-33. PubMed ID: 22955255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
    Yu JM; Li YJ; Qiu LY; Jin Y
    J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
    Gupta NK; Tomar P; Sharma V; Dixit VK
    Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and evaluation of an intravesical delivery system for superficial bladder cancer: preparation of gemcitabine HCl-loaded chitosan-thioglycolic acid nanoparticles and comparison of chitosan/poloxamer gels as carriers.
    Şenyiğit ZA; Karavana SY; İlem-Özdemir D; Çalışkan Ç; Waldner C; Şen S; Bernkop-Schnürch A; Baloğlu E
    Int J Nanomedicine; 2015; 10():6493-507. PubMed ID: 26508855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of mitomycin C on concentrations of vascular endothelial growth factor and its receptors in bladder cancer cells and in bladders of rats intravesically instilled with mitomycin C.
    Verma A; Degrado J; Hittelman AB; Wheeler MA; Kaimakliotis HZ; Weiss RM
    BJU Int; 2011 Apr; 107(7):1154-61. PubMed ID: 20735383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elaboration of chitosan-coated nanoparticles loaded with curcumin for mucoadhesive applications.
    Mazzarino L; Travelet C; Ortega-Murillo S; Otsuka I; Pignot-Paintrand I; Lemos-Senna E; Borsali R
    J Colloid Interface Sci; 2012 Mar; 370(1):58-66. PubMed ID: 22284577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.
    Oyarzun-Ampuero FA; Brea J; Loza MI; Torres D; Alonso MJ
    Int J Pharm; 2009 Nov; 381(2):122-9. PubMed ID: 19467809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer.
    Shenoy DB; Amiji MM
    Int J Pharm; 2005 Apr; 293(1-2):261-70. PubMed ID: 15778064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization to development of chitosan decorated polycaprolactone nanoparticles for improved ocular delivery of dorzolamide: In vitro, ex vivo and toxicity assessments.
    Shahab MS; Rizwanullah M; Alshehri S; Imam SS
    Int J Biol Macromol; 2020 Nov; 163():2392-2404. PubMed ID: 32979440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a mucoadhesive nanoparticulate drug delivery system for a targeted drug release in the bladder.
    Barthelmes J; Perera G; Hombach J; Dünnhaupt S; Bernkop-Schnürch A
    Int J Pharm; 2011 Sep; 416(1):339-45. PubMed ID: 21726619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan graft copolymer nanoparticles for oral protein drug delivery: preparation and characterization.
    Qian F; Cui F; Ding J; Tang C; Yin C
    Biomacromolecules; 2006 Oct; 7(10):2722-7. PubMed ID: 17025345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery.
    Lin YH; Mi FL; Chen CT; Chang WC; Peng SF; Liang HF; Sung HW
    Biomacromolecules; 2007 Jan; 8(1):146-52. PubMed ID: 17206800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules.
    Giovino C; Ayensu I; Tetteh J; Boateng JS
    Int J Pharm; 2012 May; 428(1-2):143-51. PubMed ID: 22405987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(epsilon-caprolactone)/poly(ethylene glycol)/poly(epsilon-caprolactone) nanoparticles: preparation, characterization, and application in doxorubicin delivery.
    Gou M; Zheng X; Men K; Zhang J; Zheng L; Wang X; Luo F; Zhao Y; Zhao X; Wei Y; Qian Z
    J Phys Chem B; 2009 Oct; 113(39):12928-33. PubMed ID: 19736995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.